{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT04137406",
      "OrgStudyIdInfo": {
        "OrgStudyId": "Luminal A sirt1"
      },
      "Organization": {
        "OrgFullName": "Peking University People's Hospital",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Role of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes Metastasis",
      "OfficialTitle": "Role of SIRT1 in Regulation of Epithelial-to-mesenchymal Transition in Breast Cancer Lymph Nodes Metastasis for Luminal A Subtype"
    },
    "StatusModule": {
      "StatusVerifiedDate": "October 2019",
      "OverallStatus": "Unknown status",
      "LastKnownStatus": "Recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "January 1, 2019",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "December 30, 2020",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 30, 2020",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "October 22, 2019",
      "StudyFirstSubmitQCDate": "October 22, 2019",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "October 24, 2019",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "October 22, 2019",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "October 24, 2019",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Peking University People's Hospital",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "Luminal A breast cancer is a kind of breast cancer with low rate lymph node metastasis and good survival. But in clinical practice, Luminal A breast cancer can present with early, unexpected lymph node metastasis some time, indicates poor survival. Silent information regulator 2 homolog 1 (SIRT1) plays a different role in breast cancer with different molecular typing. Previous study supports a role of SIRT1 protein as tumor suppressor in Luminal A breast cancer, in association with apoptosis-related proteins. The epithelial-to-mesenchymal transition(EMT) process results in loss of cell-cell adhesion, increased cell mobility, and is crucial for enabling the metastasis of cancer cells. But no similar study in Luminal A breast cancer. Hence, this study will 1) investigate the expression pattern of SIRT1 in primary tumor and lymph node metastasis; 2) investigate the different expression pattern of SIRT1 in T2/T3 , lymph node negative tumor and T1, lymph node positive tumor; 3) investigate potential role of SIRT1 enzyme in regulating cell migration and invasion in Luminal A breast cancer cells.",
      "DetailedDescription": "The study has three parts.\n\nIn large specimens of human Luminal A breast cancer with T1 tumor and positive axillary lymph node, study the difference expression of SIRT1 and related p53, Bcl-2, autophagy-related protein caspase-3, apaf-1 between primary tumor and lymph node metastases. Collect 50 pairs of T1 primary tumors and corresponding metastatic lymph node specimens. Using immunohistochemistry, anti-SIRT1, p53, Bcl-2, caspase-3 and apaf-1 antibody staining to identify the expression of above proteins in the primary tumor and lymph node metastases.\nEighty patients with Luminal type A breast cancer (T1N+) were enrolled in this study. At the same time,eighty patients were enrolled in the paraffin-embedded specimens of the patients with T2N+ and T3N+,too. And all patients were followed up. Immunohistochemical staining with anti-SIRT1, p53, Bcl-2, caspase-3, apaf-1, E-cadherin, N-cadherin, Vimentin antibodies to determine the relationship between above protein expression and routine clinicopathological and survival.\nExplore the involvement of SIRT1 in hormone receptor-positive human breast cancer cells at the cellular level. The molecular mechanism of EMT-related protein regulation, which affects the proliferation, invasion and metastasis of tumor cells."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Breast Cancer",
          "Lymph Node Metastases"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Luminal A breast cancer",
          "Sirt 1",
          "lymph node metastasis",
          "EMT"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Observational",
      "PatientRegistry": "No",
      "DesignInfo": {
        "DesignObservationalModelList": {
          "DesignObservationalModel": [
            "Cohort"
          ]
        },
        "DesignTimePerspectiveList": {
          "DesignTimePerspective": [
            "Retrospective"
          ]
        }
      },
      "BioSpec": {
        "BioSpecRetention": "Samples Without DNA",
        "BioSpecDescription": "Paraffin section, immunohistochemical staining"
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "160",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "T1 tumor with lymph node metastasis",
            "ArmGroupDescription": "patients with T1 tumor and lymphnode positive"
          },
          {
            "ArmGroupLabel": "T2 or T3 tumor with lymph node negative",
            "ArmGroupDescription": "patients with T2 or T3,lymph node negative"
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Protein expression difference",
            "PrimaryOutcomeDescription": "the different of sirt1 expression between T1N+ tumor and T2N0/T3M0 tumor",
            "PrimaryOutcomeTimeFrame": "2020-2"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "survival",
            "SecondaryOutcomeDescription": "the relationship of sirt1 expression level and survival",
            "SecondaryOutcomeTimeFrame": "2021-2"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nInvasive breast cancer Luminal A subtype T1 and lymph node positive or T2/T3 with negative lymph node\n\nExclusion Criteria:\n\nMissing clinical pathology data",
      "HealthyVolunteers": "No",
      "Gender": "Female",
      "StdAgeList": {
        "StdAge": [
          "Child",
          "Adult",
          "Older Adult"
        ]
      },
      "StudyPopulation": "all the patients have invasive breast cancer with luminal A subtype group 1: T1 and lymph node positve group 2: T2/T3 with negative lymph node",
      "SamplingMethod": "Non-Probability Sample"
    },
    "ContactsLocationsModule": {
      "CentralContactList": {
        "CentralContact": [
          {
            "CentralContactName": "yuan peng, Doctor",
            "CentralContactRole": "Contact",
            "CentralContactPhone": "+8613671287670",
            "CentralContactEMail": "13671287670@163.com"
          }
        ]
      },
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "shu wang, Doctor",
            "OverallOfficialAffiliation": "Peking University People's Hospital",
            "OverallOfficialRole": "Study Director"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Peking university people's hospital",
            "LocationStatus": "Recruiting",
            "LocationCity": "Beijing",
            "LocationState": "Beijing",
            "LocationZip": "100044",
            "LocationCountry": "China",
            "LocationContactList": {
              "LocationContact": [
                {
                  "LocationContactName": "yuan peng",
                  "LocationContactRole": "Contact",
                  "LocationContactPhone": "+8613671287670",
                  "LocationContactEMail": "13671287670@163.com"
                },
                {
                  "LocationContactName": "Shu Wang",
                  "LocationContactRole": "Principal Investigator"
                }
              ]
            }
          }
        ]
      }
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000001943",
            "ConditionMeshTerm": "Breast Neoplasms"
          },
          {
            "ConditionMeshId": "D000009362",
            "ConditionMeshTerm": "Neoplasm Metastasis"
          },
          {
            "ConditionMeshId": "D000016609",
            "ConditionMeshTerm": "Neoplasms, Second Primary"
          },
          {
            "ConditionMeshId": "D000008207",
            "ConditionMeshTerm": "Lymphatic Metastasis"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000009371",
            "ConditionAncestorTerm": "Neoplasms by Site"
          },
          {
            "ConditionAncestorId": "D000009369",
            "ConditionAncestorTerm": "Neoplasms"
          },
          {
            "ConditionAncestorId": "D000001941",
            "ConditionAncestorTerm": "Breast Diseases"
          },
          {
            "ConditionAncestorId": "D000012871",
            "ConditionAncestorTerm": "Skin Diseases"
          },
          {
            "ConditionAncestorId": "D000009385",
            "ConditionAncestorTerm": "Neoplastic Processes"
          },
          {
            "ConditionAncestorId": "D000010335",
            "ConditionAncestorTerm": "Pathologic Processes"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M4372",
            "ConditionBrowseLeafName": "Breast Neoplasms",
            "ConditionBrowseLeafAsFound": "Breast Cancer",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M11459",
            "ConditionBrowseLeafName": "Neoplasm Metastasis",
            "ConditionBrowseLeafAsFound": "Metastases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M18141",
            "ConditionBrowseLeafName": "Neoplasms, Second Primary",
            "ConditionBrowseLeafAsFound": "Metastases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M10356",
            "ConditionBrowseLeafName": "Lymphatic Metastasis",
            "ConditionBrowseLeafAsFound": "Lymph Node Metastases",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M4370",
            "ConditionBrowseLeafName": "Breast Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14826",
            "ConditionBrowseLeafName": "Skin Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M11482",
            "ConditionBrowseLeafName": "Neoplastic Processes",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC04",
            "ConditionBrowseBranchName": "Neoplasms"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    }
  }
}